Yukon Metals Announces CEO Transition

(CNSX:YMC.CN),(CNSX:YMC),(Boerse Frankfurt – Freiverkehr:E770),(OTC US:YMMCF),(Other OTC:YMMCF), VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) — Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF) (“Yukon Metals” or the “Company“) announces that the Board of Directors of the Company (the “”Board“) has appointed Jim Coates (Executive Vice President and a Director of the Company) as Interim […]

Ambetter Health & Tampa Bay Buccaneers Launch “Stay Healthy, Stay in the Game” PSA Urging Floridians to Prioritize Preventive Care Before Year-End

Ambetter Health,a company of Centene Corporation(NYSE:CNC) and a health insurance marketplace product offered through the federal Health Insurance Marketplace, and the Tampa Bay Buccaneers have teamed up to release a new public service announcement (PSA) titled”Stay Healthy, Stay in the Game,”encouraging Floridians to take charge of their health by engaging in preventive care and prioritizing

Yukon Metals Announces CEO Transition

Yukon Metals Announces CEO Transition GlobeNewswire December 17, 2025 VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) — Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF) (“Yukon Metals” or the “Company“) announces that the Board of Directors of the Company (the “”Board“) has appointed Jim Coates (Executive Vice President and a Director of the

CT Plan Selects DataCT as its Independent Administrator

New market data NMS plan selects Administrator in anticipation of its 2027 launch The Operating Committee of the Consolidated Tape Plan (“CT Plan”) today announced that it has selected DataCT, an independent affiliate of DataBP, to serve as the CT Plan's independent Administrator, pending the outcome of negotiations. The CT Plan requires that the new

Freeport-McMoran Inc. (FCX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE:FCX). https://mma.prnewswire.com/media/1219482/Glancy_Prongay_and_Murray_LLP.jpg IF YOU SUFFERED A LOSS ON YOUR FREEPORT INVESTMENTS, CLICKHERE BEFORE JANUARY 12, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is

Coupang Investor News: Rosen Law Firm Encourages Coupang, Inc. Investors to Inquire About Securities Class Action Investigation – CPNG

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Coupang, Inc. (NYSE: CPNG) resulting from allegations that Coupang may have issued materially misleading business information to the investing public. So What: If you purchased Coupang securities you may be entitled to compensation

New Ebook Offers First-Time Biotech CEOs a Roadmap for the Decisions That Determine Company Success

MONTREAL, Dec. 17, 2025 (GLOBE NEWSWIRE) — Three of the biotech industry's trusted advisory firms: KreaMedica, Venture Valuation, and Lacerta Bio, today announced the release of The First-Time Biotech CEO Playbook, a practical guide designed to help new biotech leaders avoid the predictable mistakes that derail early-stage companies. Built from decades of combined experience working

New Ebook Offers First-Time Biotech CEOs a Roadmap for the Decisions That Determine Company Success

New Ebook Offers First-Time Biotech CEOs a Roadmap for the Decisions That Determine Company Success Produced by KreaMedica, in partnership with Venture Valuation and Lacerta Bio: three leading advisors to early-stage biotechs GlobeNewswire December 17, 2025 MONTREAL, Dec. 17, 2025 (GLOBE NEWSWIRE) — Three of the biotech industry's trusted advisory firms: KreaMedica, Venture Valuation, and

CranioSense Awarded $5.5 Million in Federal Grants to Validate Noninvasive Neurotech

CranioSense, Inc., a neurotechnology company developing the world's first noninvasive intracranial pressure (ICP) diagnostic and monitoring system, today announced the award of approximately $5.5 million in total non-dilutive funding through the NIH Blueprint MedTech Program and the U.S. Department of Defense's Joint Warfighter Medical Research Program (JWMRP). “In over a decade of working to develop

Where Are CD Rates Headed by the End of 2025? CD Valet’s APY Checkpoint Reveals Both Short- and Long-Term Opportunities

CD Valetis a digital marketplace that connects consumers with the best verified, high-yield CD rates nationwide, helping community financial institutions effectively attract new deposits. The company today shared its December APY Checkpoint, revealing that as of 12/15/2025, 12-month CD rates shifted the most among standard term offerings across all APY benchmarks when comparing December to

Scroll to Top